Business
KRTL Biotech Inc. Introduces Expanded Pharmaceutical Portfolio Following Strategic Acquisition
KRTL Biotech Inc. Introduces Expanded Pharmaceutical Portfolio Following Strategic Acquisition.
About this update from Krtl Holding Group, Inc
[{"type":"text","content":"KRTL\r\nHolding Group, Inc. (OTC: KRTL) (“KRTL Holding” or the “Company”) today\r\nannounced that its majority owned subsidiary, KRTL Biotech, Inc. (“KRTL\r\nBiotech”), now holds exclusive rights to a robust pharmaceutical product\r\ncatalog following the recently completed merger of Industria Químico\r\nFarmacéutica SIGMA Corp SRL. agreement.\r\nThis\r\nintegration marks a significant expansion of KRTL Biotech’s capabilities across\r\nthe pharmaceutical value chain, including formulation, packaging, and\r\ndistribution of essential medications spanning more than a dozen therapeutic\r\nareas.\r\n“This\r\ncatalog reflects decades of medical advancement and our dedication to\r\ndelivering quality medicines throughout Bolivia and beyond,” said Patricia\r\nWilstermann, CEO of SIGMA. “We are honored to see our work reach new markets\r\nthrough this partnership and are confident in the value it brings to both our\r\ncommunities and KRTL Biotech’s global vision.”\r\n“With\r\nthis merger, KRTL Biotech now has access to a comprehensive pharmaceutical\r\nportfolio produced in accordance with national GMP standards and backed by\r\ndecades of successful market presence in Latin America,” said Dan Bishop, CEO\r\nof KRTL Biotech Inc. “These assets position KRTL Biotech to enter new markets\r\nand align with future U.S. regulatory initiatives.”\r\nProduct Portfolio Overview\r\nThe\r\nacquired catalog includes over 150 registered pharmaceutical products, offering\r\na strategically balanced mix of high-demand, essential therapies and\r\nspecialized health solutions. This portfolio not only reflects regional\r\nhealthcare priorities but also introduces a foundation of GMP-certified\r\nproducts that can be adapted for broader international commercialization. It\r\nspans the following categories:\r\n\r\n Antibiotics\r\n and Antivirals\r\n Digestive\r\n and Gastrointestinal Treatments\r\n Cardiological\r\n and Urological Therapies\r\n Analgesics\r\n and Anti-Inflammatories\r\n Dermatological\r\n and Ophthalmological Formulations\r\n Cognitive\r\n Enhancers and Vitamin Supplements\r\n Biosecurity\r\n Products and Dental Health Solutions\r\n Nutraceuticals\r\n and Functional Health Products\r\n\r\nThis\r\nbroad range of products—including nutraceuticals, antibiotics, cardiovascular\r\ntreatments, and pediatric formulations—reflects KRTL Biotech’s de...